Increased plasminogen activator inhibitor-1 (PAI-1) and decreased tissue-plasminogen activator (t-PA) activities lead to impaired fibrinolysis, which is critical for cardiovascular disease. We studied these hemostatic factors at fasting state and after an oral fat load in 12 type 2 diabetic and 17 nondiabetic obese adolescents, matched for age, sex, body mass index, and sexual maturation. Plasma PAI-1, t-PA, and glucose as well as serum C-peptide, insulin, total cholesterol, triglyceride, and HDL and LDL cholesterol levels were measured at 0, 2, 4, and 6 h after the fat load. Metabolic responses were expressed as the area under the curve (AUC). PAI-1 activities were significantly greater in patients than in control subjects [fasting, 23.4 Ϯ 2.6 versus 12.9 Ϯ 2.0 U/mL (p Ͻ 0.004); AUC, 101.7 Ϯ 12.1 versus 57.6 Ϯ 6.5 U · h Ϫ1 · mL Ϫ1 (p Ͻ 0.003)]. Fasting t-PA activities were significantly lower in the patients than in the control subjects (0.8 Ϯ 0.3 versus 6.5 Ϯ 2.7 U/mL; p Ͻ 0.001). Triglyceride was the only lipid parameter that was significantly different in the patients than in the control subjects [fasting, 1.5 Ϯ 0.2 versus 0.9 Ϯ 0.1 mM (p Ͻ 0.05); AUC, 15.7 Ϯ 2.9 versus Insulin resistance followed by absolute or relative insulin deficiency is a known course of type 2 diabetes development (1,2). Type 2 diabetes, obesity, dyslipidemia, and abnormal factors related to blood clotting are risk factors of cardiovascular disease (CVD) and are often seen in patients with insulin resistance (2-7). Tissue-plasminogen activator (t-PA) initiates fibrinolysis. Plasminogen activator inhibitor-1 (PAI-1) binds rapidly to t-PA and has an inhibitory activity against t-PA (6). As a result, abnormal PAI-1 and/or t-PA activities contribute to a thrombotic tendency (6). Elevated plasma PAI-1 activities and antigens have been reported in adults with type 1 diabetes, type 2 diabetes, and obesity as well as in children with type 1 diabetes and obesity (8 -20). Elevated plasma t-PA antigens have been reported in adults with type 1 diabetes, type 2 diabetes, and obesity as well as in children with type 1 diabetes and obesity (8, 13, 19, 21) . Decreased plasma t-PA activities and a decreased capacity of endothelial cells to secret t-PA in response to a fibrinolytic stimulus were also reported in adults with diabetes (7, 14, 22) . Normal PAI-1 and t-PA antigens, however, have been shown in children and adults with type 1 diabetes (17, 19) . Because there are few data about PAI-1 and t-PA in children and adolescents with type 2 diabetes, there is a continuing increase in type 2 diabetes and obesity in this population, which is thought to be due to high caloric intake and sedentary life style (especially in minority groups) (23) (24) (25) , and CVD begins in childhood (26,27), we studied the PAI-1 and t-PA activities at fasting state as well as an impact of a fat load assigned to simulate the fat content of a high-fat, fast-food meal (28) to these critical factors in minority adolescents with type 2 diabetes and obesity. 
Insulin resistance followed by absolute or relative insulin deficiency is a known course of type 2 diabetes development (1, 2) . Type 2 diabetes, obesity, dyslipidemia, and abnormal factors related to blood clotting are risk factors of cardiovascular disease (CVD) and are often seen in patients with insulin resistance (2-7). Tissue-plasminogen activator (t-PA) initiates fibrinolysis. Plasminogen activator inhibitor-1 (PAI-1) binds rapidly to t-PA and has an inhibitory activity against t-PA (6). As a result, abnormal PAI-1 and/or t-PA activities contribute to a thrombotic tendency (6) . Elevated plasma PAI-1 activities and antigens have been reported in adults with type 1 diabetes, type 2 diabetes, and obesity as well as in children with type 1 diabetes and obesity (8 -20) . Elevated plasma t-PA antigens have been reported in adults with type 1 diabetes, type 2 diabetes, and obesity as well as in children with type 1 diabetes and obesity (8, 13, 19, 21) . Decreased plasma t-PA activities and a decreased capacity of endothelial cells to secret t-PA in response to a fibrinolytic stimulus were also reported in adults with diabetes (7, 14, 22) . Normal PAI-1 and t-PA antigens, however, have been shown in children and adults with type 1 diabetes (17, 19) . Because there are few data about PAI-1 and t-PA in children and adolescents with type 2 diabetes, there is a continuing increase in type 2 diabetes and obesity in this population, which is thought to be due to high caloric intake and sedentary life style (especially in minority groups) (23) (24) (25) , and CVD begins in childhood (26, 27) , we studied the PAI-1 and t-PA activities at fasting state as well as an impact of a fat load assigned to simulate the fat content of a high-fat, fast-food meal (28) to these critical factors in minority adolescents with type 2 diabetes and obesity. and our sample size was small. Differences in the metabolic responses between the two groups and across the four time points were also examined by repeated measures ANOVA. Both Mann-Whitney tests and repeated measures ANOVA yielded similar results for the differences of the metabolic parameters during the loading tests between the two groups. Only p values from the MannWhitney tests were reported. Differences in sex and sexual maturation were examined by Fisher's exact tests. Correlations were evaluated, and multiple linear regression analyses were used when indicated. The statistical package for social sciences for Windows, version 10.5 (SPSS, Inc., Chicago, IL) was used for the statistical analyses. Significance was accepted at the level p Ͻ 0.05. Data are presented as mean Ϯ SEM.
RESULTS
Fasting state. Fasting PAI-1 activities were significantly greater in the diabetes group than in the control group. Fasting t-PA activities in the diabetes group were significantly lower than in the control group. Triglyceride was the only lipid parameter that was significantly different in the patients than in the control subjects. As expected, the fasting glucose and HbA 1c levels were significantly higher in the diabetes group when compared with the control group. The fasting C-peptide and insulin levels were also significantly greater in the diabetes group than in the control group. HOMA was greater in the patients with diabetes than in the control subjects ( Table 2) .
Postprandial state. PAI-1 AUC was significantly greater in the diabetes group than in the control group (Fig. 1A) . t-PA AUC in the diabetes group was relatively lower than in the control group (Fig. 1B) . Triglyceride responses in the diabetes group were significantly higher than in the control groups ( 
, respectively). As expected, glucose AUC was significantly higher in the diabetes group when compared with the control group (Fig. 1D) . The Cpeptide and insulin AUCs were also significantly greater in the diabetes group than in the control group ( Fig. 1E and F,  respectively) .
When we compared changes of the metabolic parameters across the four time points, PAI-1 activities decreased significantly (p Ͻ 0.0001). t-PA activities did not change. Triglycerides increased significantly (p Ͻ 0.0001). Total cholesterol levels increased significantly (p Ͻ 0.005), whereas HDL cho- lesterol levels decreased significantly (p Ͻ 0.04) and LDL cholesterol levels did not change. As expected, glucose levels did not change significantly. C-peptide and insulin levels increased significantly (p Ͻ 0.001 and 0.006, respectively). Correlations. As a whole group, fasting PAI-1 activities were significantly correlated with fasting triglycerides (r ϭ 0.54, p Ͻ 0.004), fasting insulin (r ϭ 0.50, p Ͻ 0.009), and HOMA (r ϭ 0.70, p Ͻ 0.001). Fasting t-PA activities were significantly correlated with fasting cholesterol levels (r ϭ Ϫ0.51, p Ͻ 0.009), fasting LDL cholesterol levels (r ϭ Ϫ0.52, p Ͻ 0.008), and BMI (r ϭ Ϫ0.60, p Ͻ 0.002). After multiple linear regression analyses, only correlation between fasting PAI-1 levels and HOMA remained significant. Postprandially, significant correlation was also found between PAI-1 AUCs and HOMA (r ϭ 0.78, p Ͻ 0.0001) after multiple linear regression analyses (Fig. 2) .
DISCUSSION
This study shows for the first time that adolescents with type 2 diabetes have both fasting and postprandial unfavorable PAI-1 and t-PA activities when compared with nondiabetic adolescents who are equally obese and that these profiles are not negatively affected by an acute oral high-fat load. Because PAI-1 binds rapidly to t-PA and forms an inactive t-PA-PAI-1 complex, we measured PAI-1 and t-PA activities, rather than antigens. Increased PAI-1 and decreased t-PA activities are suggestive of reduced fibrinolytic activities and are unfavorable for CVD (6, 8, 16, 19, 36) . Patients who have diabetes and developed peripheral artery disease or late complications of diabetes showed a shift toward an antifibrinolytic pathway with diminished t-PA and increased PAI-1 antigen and activity (12, 17) . Our adolescents with type 2 diabetes had mean duration of the disease of 7.1 Ϯ 2.5 mo; therefore, interference of any coexistent atherosclerosis as overt late complication of diabetes is very unlikely to affect the results of PAI-1 and t-PA measurements.
At fasting and during postprandial states, PAI-1, triglyceride, glucose, C-peptide, and insulin levels were significantly higher in patients than in control subjects. Fasting t-PA activities were significantly lower in the patients than in the control subjects. Insulin resistance, represented by HOMA, was greater in the patients than that in the control subjects. A clustering of these cardiovascular risk factors, including increased PAI-1/decreased t-PA activities, hypertriglyceridemia, diabetes, and hyperinsulinemia, increases the risk for CVD.
The increased triglyceride levels during the fat-loading tests observed in our study are consistent with findings reported by others (37) (38) (39) and have been discussed previously (40) . The relationship between elevated PAI-1, insulin resistance, and hypertriglyceridemia is established (2, 6, 17, 18, 36, 41) and is shown in our study. Therefore, elevated PAI-1 activities were anticipated during the fat-loading tests. On the contrary, the PAI-1 activities decreased significantly. Both increased and decreased PAI-1 activities after fat loads have been reported (39, (42) (43) (44) (45) (46) (47) . The difference in the postprandial PAI-1 responses has been explained by different genotypes of PAI-1, different fat types and content, and that PAI-1 has a circadian rhythm (PAI-1 concentrations decrease during the day) (39, 44, 48, 49) . Whereas increase in triglycerides alone, as here in our study, or insulin alone (50) seems insufficient to increase PAI-1 concentrations, a combination of hypertriglyceridemia, hyperinsulinemia, and hyperglycemia can increase PAI-1 in blood in normal humans (51) . Therefore, our results also support the hypothesis that several abnormal metabolic parameters are essential for the elevation of PAI-1 levels. In addition, chronic exposure to high fat loads may result differently. t-PA activities seemed unrelated to insulin resistance and were not affected by the fat-loading tests as reported previously (45) . Nevertheless, the patients with type 2 diabetes had relatively lower t-PA activities than the control subjects throughout the fat-loading tests.
The differences in the PAI-1 levels in our diabetic and nondiabetic obese subjects, who had comparable BMIs, may be due to the difference in fat distribution (52) (53) (54) (55) . However, further investigation (e.g. computed tomography or magnetic resonance imaging to measure fat distribution) is needed to determine whether indeed our diabetic subjects have central fat distribution and our obese subjects have peripheral fat distribution. Furthermore, glycation, the result of hyperglycemia in the diabetic patients, may enhance the production of PAI-1 and attenuate that of t-PA (22, 56, 57) .
We conclude that elevated PAI-1 and diminished t-PA activities, suggestive of suppressed fibrinolysis, are present in our adolescents with type 2 diabetes, adding another risk factor for CVD, and high fat intake does not further negatively affect this suppressed fibrinolysis. 
